Hangzhou Valgen Medtech Co., Ltd
Clinical trials sponsored by Hangzhou Valgen Medtech Co., Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New heart valve clip aims to ease breathing and cut hospital visits Results expected Jun 2027 (estimated)
-
New heart valve repair device could help High-Risk patients avoid surgery
Disease control Not yet recruitingThis study tests a new device called DragonFly M2 to repair leaky mitral valves in people with moderate-to-severe or severe mitral regurgitation who are at high risk for surgery. The device is inserted through a blood vessel, avoiding open-heart surgery. The study will check if t…
Sponsor: Hangzhou Valgen Medtech Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New heart valve clip aims to ease breathing and cut hospital visits
Disease control Not yet recruitingThis study tests a device called DragonFly that clips a leaky mitral valve shut, helping blood flow properly in people with heart failure. About 148 adults with moderate-to-severe or severe functional mitral regurgitation who still have symptoms despite medication will be randoml…
Sponsor: Hangzhou Valgen Medtech Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC